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Systemic lupus erythematosus (SLE) is a chronic inﬂammatory disease characterized by
the production of autoantibodies, formation of immune complexes (IC), and activation of
complement that ultimately fuel acute and/or chronic inﬂammation. Accumulation in blood
and tissues of post-apoptotic remnants is considered of etiological and pathological impor-
tance for patients with SLE. Besides receptors directly recognizing apoptotic cells, soluble
opsonins of the innate immune system bind apoptotic material dependent on the stage
of apoptosis. We describe the binding to the surface of secondary necrotic cells (SNEC)
of the serum opsonin CRP and further opsonins. We show that anti-dsDNA and anti-CRP
autoantibodies bind and sensitize SNEC. Autoantibody-sensitized SNEC were cleared by
macrophages in vitro and induced a pro-inﬂammatory cytokine response. In conclusion,
anti-CRP, CRP, and SNEC form a ternary pyrogen endowed with strong pro-inﬂammatory
capabilities which is able to maintain and perpetuate chronic inﬂammation.
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INTRODUCTION
Accumulation in blood and tissues of post-apoptotic remnants
is discussed to be of etiological and pathological importance
for patients with Systemic lupus erythematosus (SLE) since the
pathognomonic autoantigens are sequestered inside viable cells.
They are, therefore, not accessible to the immune system in
healthy persons. These autoantigens are often exposed during
cell death. The formation of major complexes containing cel-
lular debris and autoantibodies has been observed in patients
with SLE and proposed to be an important pathogen (Munoz
et al., 2009). Sensibilization of cellular remnants with autoanti-
bodies shifts the phagocytosis of dead cells from liver and spleen
to blood–borne phagocytes, which do not take up unsensitized
material. This antibody-dependent pro-inﬂammatory pathway
initiates an ampliﬁcation loop of inﬂammation and contributes
to the chroniﬁcation of the autoimmune response (Munoz et al.,
2010c).
The recognition bymacrophages, of dead cell remnants is based
on phosphatidylserine (PS) or on sugar neo-epitopes exposed on
the plasma membranes (Schlegel and Williamson, 2001; Bottcher
et al., 2006; Franz et al., 2006; Ravichandran and Lorenz, 2007).
PS is recognized either directly by receptors as a “nude” lipid, or
in combination with soluble proteins working as “adaptor mole-
cules” or “opsonins” that bridge phagocytes and dead cells. These
opsonins include milk fat globule protein MFGE8 (Hanayama
et al., 2002), growth arrest speciﬁc gene product GAS-6 (lig-
and for the receptor tyrosine kinase MerTK; Scott et al., 2001),
β-2-glycoprotein-1 (Balasubramanian and Schroit, 1998), serum-
derived protein S (Anderson et al., 2003), annexin I (Arur et al.,
2003), annexin A5 (Bondanza et al., 2004), C-reactive protein
(CRP; Janko et al., 2009), C1q (Taylor et al., 2000), mannose-
binding lectin (Nauta et al., 2004), serum amyloid P-component
(Manfredi et al., 2008), the long Pentraxin 3 (Rovere et al., 2000),
and further phospholipid or carbohydrate recognizing proteins
(Franz et al., 2006; Beer et al., 2008; Sarter et al., 2009). The bind-
ing of these opsonins is often dependent on the stage of apoptosis,
with PS recognition preceding that of carboneoepitopes (Franz
et al., 2007).All thesemoleculesmediate recognition and uptake of
dying cells bymacrophages and act as bridging opsonins thatmod-
ulate the inﬂammatory and immunogenic potential of apoptotic
material. Some of them additionally participate in complement
activation (Ogden and Elkon, 2006).
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C-reactive protein binds to damaged cell membranes via
(lyso)phosphatidylcholine and efﬁciently activates the classical
complement pathway avoiding the assembly of the membrane
attack complex (MAC). CRP acts as an opsonin supporting inges-
tion of apoptotic cells by human macrophages and plays a role in
the clearance of apoptotic cells, especially during acute phase reac-
tions (Gershov et al., 2000;Vogt et al., 2007). In the case of primary
necrosis, the action of nucleases causes an increase in the binding
of CRP to necrotic cells that may foster their silent elimination
(Janko et al., 2009).
Generally opsonins for dead cells tend to be anti-inﬂammatory
and ameliorate clearance. Their interaction with its cognate recep-
tor of the phagocytic cell often attenuates inﬂammatory responses
(Voll et al., 1997; Aderem and Underhill, 1999). In patients with
chronic inﬂammatory autoimmune diseases these opsonins for
dying or dead cells are often targets of autoantibodies (Table 1).
Intriguingly, in almost all cases the autoantibodies target only the
surface bound opsonins and ignore their circulating counterparts
(Shoenfeld et al., 2007; Sjowall et al., 2007; Bigler et al., 2009).
The autoimmune response is, therefore,directed against opsonized
material and not against the ﬂuid phase proteins (Bell et al., 1998;
Shoenfeld et al., 2007; Schaller et al., 2009). The autoantibody-
dependent engagement of Fcγ receptors may have devastating
consequences since it is prone to shift the process of waste disposal
toward inﬂammation.
Here we describe the exposure of binding sites of anti-dsDNA
autoantibodies and of innate opsonins on the surfaces of post-
apoptotic remnants and the recognition of these targets by autoan-
tibodies against dsDNA and against surface bound CRP, respec-
tively. The autoantibodies promote the release of inﬂammatory
cytokines by macrophages in both conditions. We postulate that
anti-opsonin autoantibodies,opsonins, and (post)apoptoticmate-
rial form a ternary pyrogen that fuels chronic inﬂammation in
patients with SLE.
MATERIALS AND METHODS
PATIENTS
Thirty nine patients from our outpatient clinic met the clas-
siﬁcation criteria of the American College of Rheumatology
for SLE were included in this study (Hochberg, 1997). Thirty
Table 1 | Opsonins of dead and dying cells as targets of humoral
autoimmunity.
Opsonin IgG autoantibodies reported in
C1q Siegert et al. (1991)
Protein S Oosting et al. (1993)
Annexin A5 Matsuda et al. (1994)
β2-GP1 Tincani et al. (1996)
(PS) Manfredi et al. (1998)
CRP Sjowall et al. (2002)
MBL Seelen et al. (2003)
SAP Zandman-Goddard et al. (2005)
PTX3 Bassi et al. (2010)
Annexin A1 Kretz et al. (2010)
Galectins Own data
ﬁve NHD served as a control population. An informed con-
sent was obtained from all blood donors and the study received
the ﬁnal approval from the ethics committee of the University
Hospital Erlangen. Serum samples were obtained by centrifu-
gation at 1000 g for 15 min of clotted blood, stored at −20˚C,
thawed once for ELISA, and stored again until phagocytosis
assays.
ISOLATION OF CRP
Human CRP was puriﬁed from human serum by calcium-
dependent afﬁnity chromatography with immobilized phos-
phorylcholine (Thermo Scientiﬁc, Rockford, IL, USA). The
monomeric CPR was removed by ﬁltration through Amicon Ultra
centrifugation columns (Millipore, MA, USA). The purity of
isolated CRP was assured by SDS PAGE and analytical HPLC.
SEROLOGICAL PARAMETERS
Anti-dsDNAautoantibodies were detected by the ability of speciﬁc
serum antibodies to bind radiolabeled dsDNA employing the Farr
method (Wold et al., 1968) adapted by Kredich et al. (1973).
Anti-CRP autoantibodies were detected by ELISA, brieﬂy,
NUNC maxisorp 96-well microtiter plates (Nalgene Nunc, New
York, NY, USA) were coated overnight at 4˚C with 2 μg/well
native human CRP in Coating buffer (0.1 M Na2CO3, 0.1 M
Na HCo3, pH 9,6) and blocked for 2 h with 1% BSA in PBS.
Patient sera were diluted 1:100 in 1% BSA/PBS-0.05% Tween,
added in duplicates and incubated for 60 min. After washing
with PBS-0.05% Tween, HRP-conjugated rabbit F(ab′)2 anti-
human IgG (SouthernBiotech)was diluted 1:10000 in PBS-Tween,
added to each well and incubated for 60 min. After washing
with PBS-Tween, the substrate (1 mg/ml TMB, 0.1 M Na2HPO4,
0.05 M Citric Acid, 0.006% H2O2, pH 5) was added to each
well and incubated at room temperature. After 15 min the reac-
tion was stopped with 25% sulfuric acid. Optical densities (OD)
were measured at 450 nm. To discriminate positive from nega-
tive sera a cutoff was set at the mean value of NHD population
plus 2 SD.
SECONDARY NECROTIC CELL-DERIVED MATERIAL
Periphereal blood mononuclear cells (PBMC) served as source
for secondary necrotic cell-derived material (SNEC). PBMC were
isolated from whole blood by Ficoll density gradient centrifuga-
tion using Lymphoﬂot (Bio-Rad, Dreieich, Germany). Remaining
platelets were removed by centrifugation through heat inacti-
vated fetal calf serum (FCS; Invitrogen, Karlsruhe, Germany) and
PBMC were subsequently reconstituted in PBS (Invitrogen, Karl-
sruhe, Germany). Finally SNEC was produced by UVB irradiation
(180 mJ/cm2) of PBMC. In order to achieve uniform staining
with Trypan blue (0.02%) or propidium iodide (1μg/ml) in
late stages of apoptosis, the lymphocytes were treated with heat
(56˚C) for 30 min and stored at 4˚C in PBS until use. All parti-
cles generated by this method showed homogeneous ﬂuorescence
staining, scatter, and ligand-binding characteristics detected by
ﬂow-cytometry. We further characterized SNEC by analyzing the
binding of the following ﬂuorescent labeled dying and dead cell
ligands as well as control proteins: BSA,Narcissus pseudonarcissus
lectin (Npn), acetylated low density lipoprotein (acLDL), chicken
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annexin A5 (AxA5), human CRP. Human complement compo-
nents C1q and C3c, and human IgG were detected employing
ﬂuorescent labeled speciﬁc antibodies, as control served heat inac-
tivated human serum and NHD serum, respectively. Fluorescence
microscopy pictures were done by staining SNEC with propid-
ium iodide and monoclonal antibodies recognizing dsDNA and
apoptotic nucleosomes. In the phagocytosis assays SNEC stained
with trypan blue was incubated with patients’ sera, respectively
for 30 min. Not bound serum proteins were removed by a washing
step.
For the evaluation of the role of the opsonin CRP in the for-
mation of ternary complexes, selected anti-dsDNA negative sera
from patients with SLE were previously adsorbed 2× against
immobilized Phosphorylcholine (Thermo Scientiﬁc, Rockford,
IL, USA) and SNEC to remove CRP and anti-SNEC antibodies,
respectively.
LIGAND SPECIFIC INTERACTION EMPLOYING INERT PARTICLES
We employed Sephadex beads coated with protein G (Pharma-
cia) to immobilize the anti-dsDNA monoclonal antibody 33.C9
or normal human IgG. Sephadex beads coated with phosphoryl-
choline were used to immobilize CRP in the presence or absence
of calcium. Coated beads were incubated with ﬂuorescent SNEC
for 30 min at room temperature and immediately analyzed by
ﬂuorescence microscopy.
MACROPHAGE PREPARATION
Leukocytes were isolated from heparinized human peripheral
blood by density-gradient centrifugation (Ficoll-Paque PLUS, GE
Healthcare). Monocytes were enriched by anti-CD14 microbeads
(Miltenyi Biotec). Macrophages were generated by culturing
CD14+ monocytes for 6 days in RPMI (Biochrome) supple-
mented with 1% penicillin/streptomycin and 1% glutamine
(both Gibco) and 10% heat inactivated FCS (Biochrome), in
the presence of 50 U/ml GM-CSF (Behringwerke, Marburg, Ger-
many).
PHAGOCYTOSIS ASSAYS
Phagocytosis assays were performed in two independent exper-
iments with sera from two patients with SLE of each
group (anti-dsDNA−/anti-CRP−, anti-dsDNA+/anti-CRP−,
anti-dsDNA+/anti-CRP+, anti-dsDNA−/anti-CRP+) or NHD.
Phagocytosis assays were performed as follows; macrophages
were rinsed with PBS to wash off serum components of the
macrophage differentiation medium. Macrophages were co-
cultured with trypan blue-labeled SNEC (non-opsonized or
opsonized with different patients sera) in a ratio of 1:10 in serum
free medium containing 100 ng/ml LPS at 37˚C. After 1 h non-
internalized SNEC were removed and macrophages detached with
trypsin/EDTA. Phagocytosing macrophages were quantiﬁed by
ﬂow-cytometry.
CYTOKINE QUANTIFICATION
Supernatants from phagocytosis cultures were collected after 18
or 24 h in co-culture with SNEC. Cytokines IL-8, TNF, and IL-10
were quantiﬁed by either ELISA (Peprotech) or multiplex bead
array technology (Bender Medsystems, Vienna, Austria).
STATISTICS
Association between parameters were evaluated by a bivariate cor-
relation test. Data are presented as mean± SD, with n = number
of independent experiments. Statistical signiﬁcance was evaluated
using a Student’s t test. All statistic calculations were done with
the software SPSS-Statistics 18.0.
RESULTS
SECONDARY NECROTIC CELLS-DERIVED MATERIAL EXPOSES BINDING
SITES FOR SEVERAL OPSONINS
Considering the importance of dsDNA as autoantigen in SLE and
the tight interaction between degraded nuclear DNA and CRP,
we analyzed its localization in SNEC by ﬂow-cytometry, indirect
immunoﬂuorescence, and ligand speciﬁc interaction with inert
particles. We observed that after execution of apoptosis, periph-
eral blood lymphocytes contain high amounts of degraded DNA
(Figure 1A) and show low binding of C3c, high binding of acLDL,
NPn lectin, AxA5, C1q, CRP, and IgG from patients with SLE
(Figure 1B, gray curves). Black histograms correspond to BSA–
FITC binding as control for AxA5, CRP, acLDL, NPn lectin; to
anti-C3c and anti-C1q staining in the presence of decomple-
mented serum; and to anti-IgG in the presence of NHD serum,
respectively. The binding to SNEC of C1q and of autoantibodies
from patients with SLE but not that of CRP was abolished by treat-
ment of SNEC with DNase. SNEC show a random distribution
of autoantibody (anti-dsDNA and anti-apoptotic nucleosomes)
targets on their surfaces that do not overlap with the nuclear
chromatin (Figure 1C). To test whether the binding sites for anti-
dsDNA and for CRP are not sequestered inside the SNEC but
are accessible on their surfaces we employed anti-dsDNA anti-
bodies and CRP immobilized on beads mimicking the curvature
of effector phagocytes, respectively. Co-incubation of ﬂuorescent
SNEC demonstrates its speciﬁc interaction with both immobi-
lized anti-dsDNA and immobilized CRP, respectively. SNEC was
captured by beads coated with anti-dsDNA or with CRP but not
by those coated with normal human IgG or with CRP-beads in
absence of calcium (Figures 1D,E). These experiments reveal that
(1) CRP binding sites are accessible for CRP and (2) that both
dsDNA and CRP bound to CRP binding sites are accessible for
autoantibodies and for professional phagocytes on the surfaces
of SNEC.
AUTOANTIBODIES AGAINST THE DEAD CELLS OPSONIN CRP ARE
FREQUENTLY FOUND IN PATIENTS WITH SLE AND DO NOT CORRELATE
WITH ANTI-dsDNA
C-reactive protein interacts with SNEC and may facilitate their
phagocytic clearance. SNEC–CRP complexes characterize SLE
patients and are seldom found in healthy persons, since apop-
totic cells rarely get secondary necrotic in the latter. In the absence
of proper clearance bound CRP may itself become a target for
the autoimmune response. Therefore, we measured the anti-CRP
and anti-dsDNA reactivity in sera from 39 patients with SLE and
35 NHD.
Autoantibodies of the IgG isotype were detected in 61.5 and
2.7% (p< 0.001) of the patients with SLE and of healthy donors,
respectively (Figure 2A). Anti-CRP did not correlate with anti-
dsDNA (Farr assay; Figure 2B). This allowed us to study the
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FIGURE 1 | SNEC contain DNA, detected by staining with propidium
iodide (PI) (A). SNEC bind AxA5, NPn lectin, acLDL, CRP, serum C1q, and
C3c depicted as gray curves as detected by ﬂow-cytometry (B). IgG from
patients with SLE sensitize SNEC [(B), right histograms]. BSA–FITC for
labeled opsonins, heat inactivated human serum for complement, and NHD
serum for SLE serum served as controls, respectively and are shown as
black histograms. After treatment with DNAse-1 [(B), lower row], the
binding of complement proteins and of IgG from SLE patients is reduced.
SNEC expose binding sites for monoclonal antibodies recognizing dsDNA
[(C), upper slide] and apoptotic nucleosomes [(C), lower slide]. Binding sites
for anti-dsDNA [(D) lower row] and for CRP [(E), lower row] are accessible
on the surfaces of SNEC and may, therefore, be employed by phagocytes
for uptake. Negative controls (see Materials and Methods) are displayed in
the upper rows of D/E.
individual contribution of these autoantibodies in the uptake by
macrophages of sensitized SNEC and their subsequent cytokine
responses.
SENSIBILIZATION OF SNEC WITH AUTOANTIBODIES PROMOTES THEIR
UPTAKE BY MACROPHAGES AND FUELS AN INFLAMMATORY
CYTOKINE RESPONSE
Macrophages were co-cultured with (I) pure SNEC or (II) SNEC
pre-incubated with serum from healthy donors, or (III) sera
from patients with SLE. The latter contained (IIIa) neither anti-
dsDNA nor anti-CRP, (IIIb) anti-dsDNA only, (IIIc) anti-CRP
only; (IIId) anti-dsDNA; and anti-CRP (Figure 3A). Treatment of
SNECwith autoantibody positive sera results in an elevated uptake
by macrophages, whereas phagocytosis of SNEC incubated with
autoantibody negative serum does not. Sensibilization of SNEC
with anti-dsDNA and anti-CRP antibodies promoted the highest
phagocytosis index (p< 0.05; Figure 3B).
Phagocytosis of apoptotic cells is typically anti-inﬂammatory.
We, therefore, analyzed the cytokine proﬁle of LPS triggered
FIGURE 2 | Autoantibodies against CRP are frequently found in sera of
patients with SLE (A). Anti-CRP levels do not correlate with anti-dsDNA
levels (B).
macrophages after the uptake of SNEC in the presence and absence
of opsonins. SNEC sensitized with serum of patients with SLE
induces an increased production of IL-8 and TNF and a reduced
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release of IL-10when comparedwith SNEC treatedwith the serum
of healthy donors. Figures 3C,D shows the ratios of IL-8 and
TNF in relation to IL-10. However, phagocytosis of SNEC tar-
geted with anti-dsDNA and anti-CRP antibodies promoted the
strongest inﬂammatory cytokine response as seen by the highest
IL-8 and TNF ratios (Figures 3C,D).
SNEC, THE OPSONIN CRP, AND ANTI-CRP AUTOANTIBODIES FORM
TERNARY COMPLEXES THAT SHIFT CLEARANCE OF APOPTOTIC CELLS
TOWARD INFLAMMATION
To evaluate the role of CRP, of anti-CRP autoantibodies during the
clearance process of SNEC,we depleted CRP and anti-SNEC from
anti-dsDNA negative/anti-CRP positive sera. These procedures
remove the target structure for anti-CRPantibodies aswell as other
possible anti-SNEC antibodies. Depleted and reconstituted anti-
CRP containing sera were used to sensitize SNEC for phagocytosis.
Opsonisation with CRP or sensibilization with anti-CRP antibod-
ies or both does not inﬂuence the phagocytosis by macrophages of
SNEC (Figure 4A). However, the cytokine proﬁle measured in the
culture supernatants showed a signiﬁcant higher TNF/IL-10 ratio
if SNEC was opsonized with CRP and sensitized with anti-CRP
autoantibodies, respectively (Figure 4B). The ternary complex of
SNEC, CRP, and anti-CRP fosters the pro-inﬂammatory response
of the macrophages.
DISCUSSION
In previous work, we have deﬁnitely demonstrated that autoanti-
bodies promotephagocytosis of SNECbyblood–bornephagocytes
and suggested that shuttling autoantigens into the intracellular
milieu of phagocytes is an important trigger of inﬂammatory
cytokine responses in patients with SLE (Munoz et al., 2009).
SNEC–IC containing nucleic acids can be considered as a binary
pyrogen able to induce much more damage than its single com-
ponents apart (Munoz et al., 2010b). Since patients with SLE
continuously produce SNEC, we proposed SNEC–IC as a lupus
“pathogen”playing a role in the chroniﬁcation of inﬂammation in
patients with SLE (Munoz et al., 2010c).
In the actual work we have demonstrated that not properly
cleared SNEC displays not only dsDNA on its surface but bind-
ing sites for several further opsonins. Employing inert particles we
showed the presence of binding sites for anti-dsDNA and for CRP
on the surfaces of SNEC. These are accessible to be recognized by
opsonins, autoantibodies, and ﬁnally by phagocytes. CRP report-
edly binds to SNEC via (lyso)phosphatidylcholine of disturbed
membranes (Volanakis and Wirtz, 1979), to nuclear components
like histones (Du Clos et al., 1988), and to snRNPs (Jewell et al.,
1993). Such DNA-associated proteins become more accessible
after DNA degradation during apoptosis and in post-apoptotic
cells (Janko et al., 2009).
Anti-CRP autoantibodies have a high prevalence in patients
with SLE. This ﬁnding has also been reported by several other
authors (Bell et al., 1998; Sjowall et al., 2002). The titer of anti-
CRP is associated with clinical activity but not with the levels of
circulating CRP (Sjowall et al., 2005). It has also been shown that
anti-CRP recognizes neo-epitopes of surface bound CRP which
displays a monomeric conformation (Bell et al., 1998; Sjowall
FIGURE 3 | Sensibilization with autoantibodies enhances uptake
by macrophages of SNEC and drives an inflammatory cytokine
response. Sera selected for phagocytosis assays are shown in (A).
SNEC treated with autoantibody positive sera are more efﬁciently
engulfed by macrophages (B). Sensibilization with serum of SNEC
induces an elevated macrophage cytokine response upon uptake. In
the presence of both anti-dsDNA and anti-CRP phagocytosis of SNEC
induces the highest levels of IL-8 andTNF (C,D). This indicates an
autoantibody-dependent shift toward an inﬂammatory cytokine
response.
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FIGURE 4 |Ternary complexes of autoantibodies and opsonized
apoptotic cell remnants provoke inflammation upon uptake by
macrophages.The phagocytosis by macrophages of SNEC was not
inﬂuenced by the opsonisation with CRP or sensibilization with anti-CRP or
both when compared to non-opsonized SNEC (A). However, the cytokine
proﬁle measured in the culture supernatants showed signiﬁcantly higher
TNF/IL-10 ratio if SNEC was opsonized with CRP and sensitized with
anti-CRP (B).
et al., 2002). The levels of anti-CRP and of anti-dsDNA do not
correlate as already been shown by Sjowall et al. (2002). The inde-
pendency of anti-CRP from anti-dsDNA confers target-bound
CRP a role as further autoantigen in autoimmune responses of
patients with SLE.
In this work we report the ability of sera to sensitize SNEC
for phagocytic clearance by macrophages. Enhanced phagocy-
tosis of SNEC by macrophages is observed in all conditions
where anti-dsDNA or anti-CRP, or both are present. We previ-
ously reported that anti-dsDNA sensitize SNEC and enhance their
uptake by blood–borne phagocytes (Munoz et al., 2009, 2010a).
Macrophages play a very important role in the swift engulfment of
dying cells (Voll et al., 1997). The involvement of these professional
phagocytes in the aberrant clearance process may have additional
deleterious consequences for patients with SLE, which often show
an impaired clearance capability.
During an acute phase response CRP usually increases dramat-
ically. In patients with SLE CRP is not considered as a marker for
inﬂammation – often CRP levels increase only moderately during
ﬂares. This is in striking contrast to other rheumatic diseases with
comparable amounts of tissue inﬂammation such as RA and gout
(Becker et al., 1980). High IFNα levels, prototypic for SLE ﬂares,
have been shown to suppress IL-6 induced CRP levels by human
hepatocytes in vitro (Enocsson et al., 2009). CRP has early been
identiﬁed as a component of immune complexes (IC) circulat-
ing in the plasma of patients with SLE (Maire et al., 1983). CRP
bound to circulating or sessile targets may escape detection, result-
ing in artiﬁcially low values of measurable CRP. In a clearance
deﬁciency scenario where post-apoptotic remnants accumulate,
CRP can be massively sequestered by this mechanism. We propose
that in patients with SLE dead cell bound CRP is an important tar-
get for anti-CRP antibodies compromising the normal clearance
process.
The complement system and CRP act together as an impor-
tant backup mechanism for cells that have escaped the early PS-
dependent clearance process (Gaipl et al., 2001). After opsoniza-
tion, CRP activates complement and facilitates silent clearance by
macrophages (Gershov et al., 2000). If complement is low, CRP
does not enhance the phagocytosis of late apoptotic neutrophils
(Hart et al., 2005). To exclude inﬂuences of the serum levels
of complement of individual sera we performed the phagocy-
tosis assays in the absence of complement. This argues for an
Fcγ-receptor involvement during recognition and engulfment by
macrophages of sensitized SNEC. Sensibilization of SNEC with
either anti-dsDNA or with anti-CRP present in sera from patients
with SLE signiﬁcantly increased the production bymacrophages of
inﬂammatory cytokines. We have shown that SNEC exposes bind-
ing sites for anti-dsDNA and for CRP on their surfaces and suggest
that autoantibodies recognize these targets and thereby form IC
that can be taken up by macrophages in an inﬂammatory fashion.
The maximal enhancement of uptake and inﬂammatory cytokine
production was observed employing sera containing both anti-
dsDNA and anti-CRP. This observation suggests that concomitant
sensibilization with both autoantibody speciﬁcities results in a
higher density of antibodies bound to the surfaces of the target
particles. The spatial vicinity of the Fc portions is critical to trigger
Fcγ-receptor mediated phagocytosis (Allen and Aderem, 1996).
Kenyon et al. (2011) recently showed that anti-C3 antibodies in
sera from autoimmune mice inhibited uptake of apoptotic cells by
blocking C3 recognition by mouse macrophages suggesting that
autoantibodies against the dead cell opsonin C3 may contribute
to a further suppression of apoptotic cell disposal increasing
severity and/or exacerbations in SLE (Kenyon et al., 2011). On
the ﬁrst view this contradicts our results. However, phagocyto-
sis assays crucially depend on experimental details. In contrast
to the settings of Kenyon et al. (2011) our phagocytosis assays
were performed under serum free conditions. After opsonisation,
SNEC was washed twice and resuspended in serum free medium.
Therefore, only molecules bound to the target-cells inﬂuenced the
outcome of phagocytosis.
We employed anti-dsDNA negative sera from patients with SLE
and depleted CRP and anti-SNEC, to analyze if circulating CRP is
part of a major IC containing SNEC and anti-CRP. Although the
indices of SNEC phagocytosis by macrophages were not increased
by opsonisation with CRP and/or sensibilization with anti-CRP,
the presence of anti-CRP and SNEC-bound CRP induced a strong
TNF response of macrophages. The presence of anti-CRP at the
phagocytic synapse formed by phagocytes and SNEC might be
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decisive to start the signaling process that results in cytokine
production. Our ﬁndings that anti-opsonin antibodies shift the
clearance toward inﬂammation are in agreement with previous
ﬁndings by Rovere et al. (1999) who reported that anti-beta 2-GP1
antibodies bound to apoptotic cells skew their immunogenicity,
enabling DCs to present their antigen with higher efﬁciency and
secrete pro-inﬂammatory cytokines.
The fact that many opsonins for dead cells are also targeted
by IgG autoimmune responses (Table 1) place them in the “crime
scene” during the challenge of the tolerance in germinal centers of
patients with SLE (Baumann et al., 2002). Anti-CRP in a patient
with persistent deﬁciency for the early anti-inﬂammatory clear-
ance of apoptotic cells provides the optimal condition to form
ternary pro-inﬂammatory IC composed of anti-CRP, CRP, and
SNEC. The Figure 5 shows a schematic representation of the
usual and the alternative interactions among SNEC, opsonins,
and phagocytes. We conclude that sensibilization by autoanti-
bodies of SNEC, either directly or indirectly, shifts the clearance
process by macrophages toward inﬂammation. The role of the
individual receptors involved in this alternative and pathological
phagocytosis pathway may differ amongst individual patients.
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